128 related articles for article (PubMed ID: 12499775)
1. The leukocyte antigen CD43 is expressed in different cell lines of nonhematopoietic origin.
Fernandez-Rodriguez J; Andersson CX; Laos S; Baeckström D; Sikut A; Sikut R; Hansson GC
Tumour Biol; 2002; 23(4):193-201. PubMed ID: 12499775
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms involved in CD43-mediated apoptosis of TF-1 cells. Roles of transcription Daxx expression, and adhesion molecules.
Cermák L; Símová S; Pintzas A; Horejsí V; Andera L
J Biol Chem; 2002 Mar; 277(10):7955-61. PubMed ID: 11773067
[TBL] [Abstract][Full Text] [Related]
3. Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain.
Sikut R; Andersson CX; Sikut A; Fernandez-Rodriguez J; Karlsson NG; Hansson GC
Int J Cancer; 1999 Jul; 82(1):52-8. PubMed ID: 10360820
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.
Brown TJ; Shuford WW; Wang WC; Nadler SG; Bailey TS; Marquardt H; Mittler RS
J Biol Chem; 1996 Nov; 271(44):27686-95. PubMed ID: 8910360
[TBL] [Abstract][Full Text] [Related]
5. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line.
Baeckström D; Zhang K; Asker N; Rüetschi U; Ek M; Hansson GC
J Biol Chem; 1995 Jun; 270(23):13688-92. PubMed ID: 7775421
[TBL] [Abstract][Full Text] [Related]
6. Specific monoclonal antibodies against leukocyte-restricted cell surface molecule CD43 react with nonhematopoietic tumor cells.
Santamaría M; López-Beltrán A; Toro M; Peña J; Molina IJ
Cancer Res; 1996 Aug; 56(15):3526-9. PubMed ID: 8758921
[TBL] [Abstract][Full Text] [Related]
7. Parallel pattern of expression of CD43 and of LFA-1 on the CD45RA+ (naive) and CD45RO+ (memory) subsets of human CD4+ and CD8+ cells. Correlation with the aggregative response of the cells to CD43 monoclonal antibodies.
Youseffi-Etemad R; Axelsson B
Immunology; 1996 Mar; 87(3):439-46. PubMed ID: 8778031
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Tn antigen on T-lymphoid cell line Jurkat.
Nakada H; Inoue M; Tanaka N; Numata Y; Kitagawa H; Fukui S; Yamashina I
Biochem Biophys Res Commun; 1991 Sep; 179(2):762-7. PubMed ID: 1716888
[TBL] [Abstract][Full Text] [Related]
9. Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43.
Sikut R; Nilsson O; Baeckström D; Hansson GC
Biochem Biophys Res Commun; 1997 Sep; 238(2):612-6. PubMed ID: 9299561
[TBL] [Abstract][Full Text] [Related]
10. Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line.
Baeckström D
J Biol Chem; 1997 Apr; 272(17):11503-9. PubMed ID: 9111064
[TBL] [Abstract][Full Text] [Related]
11. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.
Zhang K; Baeckström D; Brevinge H; Hansson GC
Tumour Biol; 1997; 18(3):175-87. PubMed ID: 9143414
[TBL] [Abstract][Full Text] [Related]
12. CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids.
Babina M; Weber S; Henz BM
Eur J Immunol; 1997 May; 27(5):1147-51. PubMed ID: 9174604
[TBL] [Abstract][Full Text] [Related]
13. Comparative CD43 behavior on monocytes and lymphocytes in kidney transplants.
Jégo S; Sabri S; Soler M; Farnarier C; Lucioni A; Dussol B; Bongrand P; Berland Y; Foa C
Nephron; 2000 Nov; 86(3):292-7. PubMed ID: 11096286
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF.
Kadaja L; Laos S; Maimets T
Oncogene; 2004 Apr; 23(14):2523-30. PubMed ID: 14676827
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica.
Sutherland DR; Abdullah KM; Cyopick P; Mellors A
J Immunol; 1992 Mar; 148(5):1458-64. PubMed ID: 1371528
[TBL] [Abstract][Full Text] [Related]
16. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.
Bazil V; Strominger JL
Proc Natl Acad Sci U S A; 1993 May; 90(9):3792-6. PubMed ID: 7683406
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
[TBL] [Abstract][Full Text] [Related]
18. Production and the characterization of monoclonal antibody against CD43, K06.
Park WS; Chae JS; Jung KC; Choi WJ; Kook MC; Bae Y
Tissue Antigens; 2004 Jan; 63(1):46-53. PubMed ID: 14651523
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CD43 in RAEB and RAEB-T patients. Report of 3 cases.
Kyriakou DS; Alexandrakis M; Tzardi M; Stephanaki D; Eliopoulos GD
Am J Hematol; 2000 Jan; 63(1):20-7. PubMed ID: 10602163
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CD43 isoforms on murine T cells and their relationship to acute intestinal graft versus host disease: studies using enhanced-green fluorescent protein transgenic mice.
Bagriaçik EU; Armstrong MD; Okabe M; Klein JR
Int Immunol; 1999 Oct; 11(10):1651-62. PubMed ID: 10508183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
